← k3vl4r
Log inGet started →

CELC (Celcuity Inc) Price Forecast

AI-generated price forecast for Celcuity Inc (CELC) across 1-hour, 4-hour, daily and weekly horizons — updated continuously, with a public accuracy track record.

As of August 2026: K3vl4r's AI model currently reads CELC as 2/2 bearish · strong across its horizons (0 of 2 timeframes pointing up), with a last price of 92.49. See our public, auditable track record →

📈 Daily Top Picks beating the S&P 500 since launch→✓ Public, verifiable track record Live system status💎 Get the full AI report · pay with XRP

Last price

92.49

AI outlook

2/2 bearish · STRONG

Timeframes up

0 / 2

Share𝕏 Post✈ Telegram

CELC forecast by horizon

HorizonDirectionProjected move (end of horizon)Bullish prob.
1-hour———
4-hour~8 weeks out———
Daily~5 months out▼ Down-28.30%0%
Weekly~1.9 years out▼ Down-81.12%—

Latest CELC news

From the market-news feed the forecasts are read against.

  • Celcuity's REVTORPYK Receives Recommendation From National Comprehensive Cancer Network Clinical Practice Guidelines In Oncology As Preferred Category 1 Second-Line Therapy · Benzinga · Jul 30
  • Why This Biotech Stock, With Its First FDA Approval, Just Crashed By Double Digits · Yahoo · Jul 15
  • Celcuity Inc. (CELC) Discusses FDA Approval of REVTORPYK for Advanced HR+/HER2- Breast Cancer and Commercial Launch Plans Transcript · SeekingAlpha · Jul 15
  • Celcuity: 'Buy' REVTORPYK FDA Approval First And sNDA Label Expansion Q3 2026 · SeekingAlpha · Jul 15
  • Celcuity gains FDA approval for closely-watched breast cancer drug · BioPharma Dive · Jul 15

🔒

See the full CELC forecast

Interactive forecast chart, price targets, and Monte-Carlo confidence bands — plus the daily AI Top Picks book. Free to start, no card required.

Create a free account →

Already have one? Log in

CELC forecast — frequently asked

Will CELC go up?

K3vl4r's AI model currently reads CELC as 2/2 bearish · STRONG — 0 of 2 forecast horizons point up, so the overall read is leaning to the downside. This is a model-generated forecast for information only — not investment advice, and forecasts may be inaccurate.

What is the CELC price prediction for 2026?

K3vl4r's model projects CELC toward $92.32 over the next ~5 months, a -0.3% move from $92.58. Projections update continuously as new data arrives and are inherently uncertain. This is a model-generated forecast for information only — not investment advice, and forecasts may be inaccurate.

What price could CELC reach?

Over its longest horizon (~~1.9 years), the model's projected target for CELC is $91.74 (-0.8% vs $92.49). Confidence decreases the further out the horizon, so treat longer-range targets as one scenario, not a guarantee. This is a model-generated forecast for information only — not investment advice, and forecasts may be inaccurate.

Part of Healthcare forecasts — browse the full sector.

More AI forecasts

PDSBAVTXAEMDZURAABEOMBRXMGRXALTNXLALGNAGENVNRXAUPHSNDA

Will CELC reach…?

Will CELC reach $200.00?Will CELC reach $250.00?Will CELC reach $500.00?

Or see the full CELC price prediction (2027–2040), or the forecast for today, tomorrow and this week.

Compare CELC

CELC vs PDSBCELC vs AVTXCELC vs AEMDCELC vs ZURACELC vs ABEOCELC vs MBRX

Curious how this is generated? Read how K3vl4r forecasts — the model, the confidence bands, and what we deliberately do not claim.

K3vl4r publishes a public, auditable track record of its Daily Top Picks — see the live results.

Forecasts are model-generated estimates for informational purposes only and are not financial advice. Markets are risky; past accuracy does not guarantee future results. See our Risk Disclosure.

k3vl4rTop PicksTrack recordChart indicatorsToday's outlookBiggest moversMarket heatmapForecasts by sectorAI reportsMarket videosCompareMethodologyBest AI toolsAboutFAQ◈ KVLHow KVL worksTokenomicsPricingX (Twitter)YouTube — daily showsTikTokTwitch — live forecastingDiscord community

Join the community on Discord and catch live forecasting on Twitch. Create a free account →

Forecasts are AI-generated; written analysis is AI-assisted and human-reviewed. Informational only, not financial advice. See Terms, Risk Disclosure, Privacy · Methodology · Status.